Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer (LISA)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Ontario Clinical Oncology Group (OCOG)
ClinicalTrials.gov Identifier:
NCT00463489
First received: April 19, 2007
Last updated: May 5, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2018
  Estimated Primary Completion Date: May 2018 (Final data collection date for primary outcome measure)